I-tirzpatide ye-tirzpatide ucocekile of Sulty i-99% ye-Peptrade Powder TR 10MG i-15mg i-20mg 20MG 20MG 30MG kwi-vial yeswekile yegazi / iswekile

I-tirzepatide yi-Novel Glucose-ixhomekeke kwi-InVeCoTROPIC ye-Inpecaic PolypePide / Glucagon-Agpper (GLP-1) i-Agonist ivunyiwe kwi-United States kwi-odocemic kulawulo lwe-odocemic kubantu abanesifo seswekile kwi Ulawulo lweMoto leNgqondo, i-Cardiovasculas enkulu kunye nokulawulwa kweminye imeko, kubandakanya ukungaphumeleli kwentliziyo kunye nokutyeba kakhulu kunye nokutyeba kakhulu kunye ne-steatohepatitis enganxibiyo. Inkqubo yeSigaba se-3 yeKlinikhi yeKlinikhi yeKlinikhi ye-1-5 yenzelwe ukuvavanya ukusebenza kunye nokhuseleko lwe-tirzhayi nge veki nganye, njengoko unyango lwe-5, 10 kunye nonyango lwabantu oluneswekile. Ukusetyenziswa kwe-tirzpatide kwizifundo zeklinikhi kwanxulunyaniswa nokuncitshiswa kwe-hemoglobin eguqulweyo (-1.87 ukuya kuthi ga -2.5.9 mmol), kunye nokuncitshiswa komzimba (kunye nokuncitshiswa kwemilinganiselo eqhelekileyo Ukunxulunyaniswa nomngcipheko we-Cardiometaboble evuthayo njengoxinzelelo lwegazi, i-visceral adhissul kunye nokujikeleza ezinye iziqwengana. UTirzepatide wanyamezeleka kakuhle, ngomngcipheko ophantsi we-hypoglycaemia xa isetyenziswa ngaphandle kwe-insulin okanye i-insulin camgoes kwaye ibonise iprofayili efanayo yokhuseleko kwi-GLP-1 ye-Agonist Agonist Agonist. Ngokuhambelana, ubungqina obuvela kula mvavanyo zeklinikhi lucebisa ukuba iTirzeatide ibonelela ngamathuba amatsha okuthotyelwa kwe-hemoglobin ekhutshiweyo ye-hemoglobin kunye nobunzima bomzimba kubantu abadala.